Patents Assigned to Axis Shield ASA
-
Patent number: 7279283Abstract: The invention provides an assay method for the determination of transcobalamin II (TC II) bound cobalamin in a body sample, comprising contacting a cell free sample of a body fluid with an immobilised or immobilizable specific binding ligand for TC II or cobalamin bound TC II (holo TC II), separating a ligand bound fraction from a non-ligand bound fraction and measuring the holo-TC II or TC-II bound cobalamin content therein.Type: GrantFiled: October 4, 2000Date of Patent: October 9, 2007Assignee: Axis-Shield ASAInventors: Erling Sundrehagen, Lars Orning
-
Patent number: 7166473Abstract: The invention relates to an assay method for assessing a transferrin variant or combination of transferrin variants for the diagnosis and monitoring of alcoholism, and to kits for performing the assay. In particular, the invention provides a method of producing an algorithm for determining the content of a transferrin variant or combination of transferrin variants, preferably a CDT variant or combination of CDT variants, in a sample of body fluid, said method comprising: (a) obtaining at least two solutions each having known contents of asialo- (A1, A2, A3, etc.) and disialo-transferrins (D1, D2, D3, etc.); (b) determining the content in each of said solutions of a transferrin variant or combination of transferrin variants fractions substantially free from tri- and higher sialylated transferring; (c) determining the total transferrin variant content (T1, T2, T2, etc.Type: GrantFiled: June 10, 2002Date of Patent: January 23, 2007Assignee: Axis-Shield ASAInventors: Erling Sundrehagen, Asgeir Husa, Ingar Eilertsen
-
Publication number: 20060240570Abstract: The present invention provides a specific binding partner for holoTC having a specificity for holoTC over apoTC of at least 40-fold and an assay method for assaying for holoTC in a sample, the method comprising contacting the sample with a specific binding partner for holoTC and detecting the resultant conjugates.Type: ApplicationFiled: November 26, 2003Publication date: October 26, 2006Applicant: Axis-Shield ASAInventors: Lars Ă–rning, Anne Rian
-
Publication number: 20060216766Abstract: A method for assaying for a protein having at least two isoforms having different glycosylation patterns, the method including contacting a sample containing the protein with a proteolytic enzyme, and detecting the content or relative content of at least one peptide fragment produced by proteolysis of the protein.Type: ApplicationFiled: February 6, 2004Publication date: September 28, 2006Applicant: Axis-Shield ASAInventor: Philip Rye
-
Publication number: 20050148022Abstract: The present invention relates to assay methods for the determination of cobalamin or vitamin B12 in a body fluid and in particular to assay methods for the metabolically active pool of cobalamin, comprising contacting a cell free sample of a body fluid with an immobilised or immobilizable specific binding ligand for TC II or holo TC II, separating a ligand bound fraction from a non-ligand bound fraction and measuring the holo-TC II or TC-II bound cobalamin content therein.Type: ApplicationFiled: July 23, 2004Publication date: July 7, 2005Applicant: Axis-Shield ASAInventors: Erling Sundrehagen, Lars Orning
-
Patent number: 6716641Abstract: The invention relates to a new dipstick assay for detecting and quantifying the content of an target analyte in a sample. The assay is particularly useful for example in the diagnosis and monitoring of alcoholism by the detection of asialo transferrin or carbohydrate free transferrin (CFT). Thus, provided is a dipstick for determining the content of a target analyte variant in a mixture of analyte variants in a sample, comprising: a) a sample application zone, b) a screening zone having an immobilised binding ligand having a binding affinity for a non-target analyte variant or varinats, c) a conjugate zone comprising a detector reagent, d) a reading zone for detection of said analyte.Type: GrantFiled: September 14, 2001Date of Patent: April 6, 2004Assignee: Axis-Shield ASAInventor: Erling Sundrehagen
-
Patent number: 6417006Abstract: An assay method for detecting potential cardiovascular disease (CVD) in a vascularized subject by assessing the concentration of holo-transcobalamin II (holo-TCII) in a sample from the subject where abnormally low levels of holo-TCII are indicative of CVD or susceptibility to CVD.Type: GrantFiled: October 5, 2000Date of Patent: July 9, 2002Assignee: Axis Shield ASAInventor: Erling Sundrehagen
-
Patent number: 6103478Abstract: The invention provides a method of assessment of carbohydrate-deficient transferrin in a transferrin containing body fluid, said method comprising the steps of:i) obtaining a transferrin containing liquid sample of or derived from a said fluid;ii) contacting said sample with a source of iron ions;iii) subsequently contacting said sample with an anionic ion exchange resin at a pH such as to cause carbohydrate-deficient transferrin to be retained by said resin;iv) subsequently contacting said resin with an eluant serving to release carbohydrate-deficient transferrin into the eluate from said resin;v) collecting a volume of said eluate substantially free from tetra- and penta-sialo transferrin; andvi) assessing the transferrin variant content in said volume of eluate.By including at least a proportion of the trisialotransferrin in the eluate, it is possible to use relatively simple assessment techniques such as turbidimetry in the assay.Type: GrantFiled: February 19, 1998Date of Patent: August 15, 2000Assignee: Axis-Shield ASAInventor: Erling Sundrehagen
-
Patent number: 6063581Abstract: The invention relates to a method for assaying homocysteine in a sample such as blood, plasma or urine, which comprises the steps of contacting the sample with a homocysteine converting enzyme and at least one substrate for the enzyme other than homocysteine, and without chromatographic separation, assessing a non-labelled analyte selected from a homocysteine co-substrate and the homocysteine conversion products of the enzymic conversion of homocysteine by said enzyme.Type: GrantFiled: September 14, 1994Date of Patent: May 16, 2000Assignee: Axis-Shield ASAInventor: Erling Sundrehagen
-
Patent number: 6054322Abstract: A method for the determination of an individual's alcohol consumption, characterized in comprising the steps: i) determining the level of sialic acid in a body fluid sample from the individual; ii) comparing the level found in step (i) with the level for the normal population, an increased level being an indication of an increased alcohol consumption relative to the consumption (per individual) of the normal population.Type: GrantFiled: February 28, 1997Date of Patent: April 25, 2000Assignee: Axis-Shield ASAInventors: Pekka Sillanaukee, Kaija Seppa, Ola M.ang.rtensson